Dr. Osman discusses a patient case study highlighting the use of BTK inhibitors for CLL management
Dr. Hani Osman, UAE
Dr. Hani Osman, Consultant Haematologist, Tawam Hospital, United Arab Emirates, speaks about the CLL Management in Clinic and provides the following details:
• Details about the case report of relapsed CLL patient’s journey from his clinic.
• Discusses patient’s initial treatment with first generation BTK inhibitor ibrutinib and development of intolerable side effects.
Patient later being shifted to second generation BTK inhibitor based on NCCN recommendations.
Explore more videos
Review on Time to Progression Regimen in CLL Management
Dr. George Follows, UK
Review on Fixed Duration Regimen in CLL Management
Dr. Mahmoud Marashi, UAE
Translating Data Into Practice
Dr. Ihab El-Hemaidi, KSA